Now you see me: lights on Merkel Cell Carcinoma.

IF 1.7 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Cristiano Pini, Giovanni Matassa, Fabrizia Gelardi, Lidija Antunovic
{"title":"Now you see me: lights on Merkel Cell Carcinoma.","authors":"Cristiano Pini,&nbsp;Giovanni Matassa,&nbsp;Fabrizia Gelardi,&nbsp;Lidija Antunovic","doi":"10.1186/s41824-023-00164-7","DOIUrl":null,"url":null,"abstract":"<p><p>Merkel Cell Carcinoma (MCC) is a rare primary cutaneous cancer with aggressive behaviour and poor prognosis. Although MCC cells express somatostatin receptors (SSTR), SSTR-targeted PET/CT is not routinely performed in clinical practice. In contrast, the use of [<sup>18</sup>F]FDG PET/CT is more widespread and its prognostic role is well established. We present the case of an MCC patient suspected recurrence who underwent restaging with both [<sup>18</sup>F]FDG and [<sup>68</sup> Ga]Ga-DOTA-TOC PET/CT. [<sup>18</sup>F]FDG PET/CT showed pathological uptake only in mediastinal lymph nodes, but SSTR imaging also revealed multiple liver and skeletal metastases, leading to significant disease upstaging and relevant changes in the therapeutic management.</p>","PeriodicalId":36160,"journal":{"name":"European Journal of Hybrid Imaging","volume":"7 1","pages":"6"},"PeriodicalIF":1.7000,"publicationDate":"2023-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025171/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hybrid Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41824-023-00164-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Merkel Cell Carcinoma (MCC) is a rare primary cutaneous cancer with aggressive behaviour and poor prognosis. Although MCC cells express somatostatin receptors (SSTR), SSTR-targeted PET/CT is not routinely performed in clinical practice. In contrast, the use of [18F]FDG PET/CT is more widespread and its prognostic role is well established. We present the case of an MCC patient suspected recurrence who underwent restaging with both [18F]FDG and [68 Ga]Ga-DOTA-TOC PET/CT. [18F]FDG PET/CT showed pathological uptake only in mediastinal lymph nodes, but SSTR imaging also revealed multiple liver and skeletal metastases, leading to significant disease upstaging and relevant changes in the therapeutic management.

Abstract Image

Abstract Image

Abstract Image

现在你看到我了:默克尔细胞癌。
梅克尔细胞癌(MCC)是一种罕见的原发性皮肤肿瘤,具有侵袭性,预后差。尽管MCC细胞表达生长抑素受体(SSTR),但SSTR靶向PET/CT在临床实践中并不常见。相比之下,[18F]FDG PET/CT的使用更为广泛,其预后作用也得到了很好的证实。我们报告一例怀疑复发的MCC患者,接受了[18F]FDG和[68 Ga]Ga- dota - toc PET/CT的重新分期。[18F]FDG PET/CT仅显示纵隔淋巴结的病理性摄取,但SSTR成像也显示多发肝脏和骨骼转移,导致疾病明显提前期和治疗管理的相关变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Hybrid Imaging
European Journal of Hybrid Imaging Computer Science-Computer Science (miscellaneous)
CiteScore
3.40
自引率
0.00%
发文量
29
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信